New research article in The Lancet Infectious Diseases>
Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, #VietNam: a parallel, single-blind, randomised controlled trial
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2823%2900061-0/fulltext
New research article in The Lancet Child & Adolescent Health>
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and #StreptococcusPneumoniae colonisation in children in #SouthAfrica: a single-centre, open-label, randomised trial
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642%2823%2900025-1/fulltext
#PCV #southafrica #streptococcuspneumoniae
New research article in The Lancet Infectious Diseases> Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00734-4/fulltext #PCV